ADVM - Adverum Biotechnologies, Inc.

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
No. of Analysts2223
Avg. Estimate-0.35-0.37-1.31-1.34
Low Estimate-0.36-0.37-1.32-1.49
High Estimate-0.33-0.36-1.3-1.25
Year Ago EPS-0.54-0.38-3.14-1.31
Revenue EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
No. of Analysts1123
Avg. Estimate500k300k1.64M970k
Low Estimate500k300k1.39MN/A
High Estimate500k300k1.9M1.9M
Year Ago Sales488k462k1.46M1.64M
Sales Growth (year/est)2.50%-35.10%12.70%-40.90%
Earnings History12/30/20163/30/20176/29/20179/29/2017
EPS Est.-0.3-0.31-0.37-0.29
EPS Actual-0.54-0.38-0.27-0.32
Difference-0.24-0.070.1-0.03
Surprise %-80.00%-22.60%27.00%-10.30%
EPS TrendCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
Current Estimate-0.35-0.37-1.31-1.34
7 Days Ago-0.35-0.37-1.31-1.34
30 Days Ago-0.33-0.35-1.28-1.31
60 Days Ago-0.31-0.34-1.26-1.31
90 Days Ago-0.31-0.3-1.26-1.27
EPS RevisionsCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Down Last 90 DaysN/AN/AN/AN/A
Growth EstimatesADVMIndustrySectorS&P 500
Current Qtr.35.20%N/AN/A0.22
Next Qtr.2.60%N/AN/A0.25
Current Year58.30%N/AN/A0.08
Next Year-2.30%N/AN/A0.12
Next 5 Years (per annum)N/AN/AN/A0.10
Past 5 Years (per annum)N/AN/AN/AN/A